These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1175 related articles for article (PubMed ID: 25282284)
1. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284 [TBL] [Abstract][Full Text] [Related]
2. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285 [TBL] [Abstract][Full Text] [Related]
3. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977 [TBL] [Abstract][Full Text] [Related]
5. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640 [TBL] [Abstract][Full Text] [Related]
6. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070 [TBL] [Abstract][Full Text] [Related]
7. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial. Guldbrandt LM Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876 [TBL] [Abstract][Full Text] [Related]
8. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S; Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736 [TBL] [Abstract][Full Text] [Related]
9. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620 [TBL] [Abstract][Full Text] [Related]
10. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Horeweg N; van der Aalst CM; Vliegenthart R; Zhao Y; Xie X; Scholten ET; Mali W; Thunnissen E; Weenink C; Groen HJ; Lammers JW; Nackaerts K; van Rosmalen J; Oudkerk M; de Koning HJ Eur Respir J; 2013 Dec; 42(6):1659-67. PubMed ID: 23845716 [TBL] [Abstract][Full Text] [Related]
11. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification based on screening history: the NELSON lung cancer screening study. Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Walter J; Nackaerts K; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H Thorax; 2017 Sep; 72(9):819-824. PubMed ID: 28360223 [TBL] [Abstract][Full Text] [Related]
13. Management of lung nodules detected by volume CT scanning. van Klaveren RJ; Oudkerk M; Prokop M; Scholten ET; Nackaerts K; Vernhout R; van Iersel CA; van den Bergh KA; van 't Westeinde S; van der Aalst C; Thunnissen E; Xu DM; Wang Y; Zhao Y; Gietema HA; de Hoop BJ; Groen HJ; de Bock GH; van Ooijen P; Weenink C; Verschakelen J; Lammers JW; Timens W; Willebrand D; Vink A; Mali W; de Koning HJ N Engl J Med; 2009 Dec; 361(23):2221-9. PubMed ID: 19955524 [TBL] [Abstract][Full Text] [Related]
14. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study. Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055 [TBL] [Abstract][Full Text] [Related]
16. Quantification of growth patterns of screen-detected lung cancers: The NELSON study. Heuvelmans MA; Vliegenthart R; de Koning HJ; Groen HJM; van Putten MJAM; Yousaf-Khan U; Weenink C; Nackaerts K; de Jong PA; Oudkerk M Lung Cancer; 2017 Jun; 108():48-54. PubMed ID: 28625647 [TBL] [Abstract][Full Text] [Related]
18. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study. Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848 [TBL] [Abstract][Full Text] [Related]
19. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen. Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995 [TBL] [Abstract][Full Text] [Related]